天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片
TargetMol中國(guó)(陶術(shù)生物) Company Information
Company Name:
TargetMol Chemicals Inc.
Tel:
-
Email:
marketing@targetmol.cn
Nationality:
China
WebSite:
https://www.targetmol.cn/
Product List:
20622
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
Product List
Carbonic anhydrase inhibitor 11
2411059-71-5
GGTI-286 hydrochloride
181141-66-2
TDP1 Inhibitor-2
859142-95-3
Y08175
2223014-57-9
Syk Inhibitor II dihydrochloride dihydrate
1965323-05-0
JNc-440
1119503-63-7
Panamesine
139225-22-2
SGLT1/2-IN-1
1673514-65-2
KRAS G12C inhibitor 29
847337-63-7
Microtubule inhibitor 3
1236141-96-0
ALOX15-IN-2
2764818-23-5
Bromperidol hydrochloride
59453-24-6
Rafutrombopag
2600513-51-5
(Z)-Fluoxastrobin
887973-21-9
Anti-melanoma agent 1
2418579-17-4
HIV-1 inhibitor-42
2459929-46-3
VII-31
2305757-96-2
GABAA receptor modulator-2
2413850-54-9
GNE-9278
2315311-83-0
AMPK-IN-3
2417674-27-0
STAT3-IN-13
2248552-86-3
IDH1 Inhibitor 5
1940128-37-9
BuChE-IN-1
2669070-40-8
FLT3-IN-12
2499966-67-3
TYK2-IN-12
2244061-66-1
KRAS inhibitor-17
2230873-65-9
AS1134900
149760-98-5
Vulolisib
2390105-79-8
TM-1
921099-13-0
KRAS inhibitor-18
2230873-66-0
Aurora kinase inhibitor-9
2419107-09-6
IHMT-MST1-58
2414484-25-4
VVD-118313
2875046-27-6
Dalmelitinib
1637658-98-0
ET-JQ1-OH
2421153-77-5
PI3K/mTOR Inhibitor-9
1392421-71-4
HIV-1 inhibitor-33
2395777-43-0
CDK7/12-IN-1
2654075-94-0
ZY-444
1802650-31-2
EIF2α activator 2
1501618-04-7
Senexin C
2375554-02-0
MARK-IN-4
1990492-86-8
Lazuvapagon
2379889-71-9
FLT3-IN-15
2435562-99-3
Posenacaftor
2095064-05-2
SHP504
2222280-83-1
Estrogen receptor α antagonist 1
2580941-45-1
Xininurad
2365178-28-3
Topoisomerase II inhibitor 4
2560590-49-8
Microtubule inhibitor 4
2411962-64-4
CCR8 antagonist 2
2756350-98-6
BAY 2476568
2311901-93-4
Carbonic anhydrase inhibitor 7
546105-61-7
TLR7 agonist 4
2413016-42-7
CB1/2 agonist 2
2772379-97-0
KVI-020
1000306-34-2
ERK1/2 inhibitor 7
2648455-13-2
hGPR91 antagonist 3
1314796-31-0
GPR41 agonist-1
506417-09-0
CJJ300
1807631-83-9
Trk-IN-9
2758623-12-8
Aha1/Hsp90-IN-1
2768265-58-1
FLT3-IN-11
2499966-50-4
TRPC6-IN-3
2311863-36-0
GABAA receptor agent 2 TFA
1781880-44-1
OM-1700
2406276-78-4
HIV-1 inhibitor-25
2475658-74-1
KRAS G12C inhibitor 53
2761968-93-6
FLT3/ITD-IN-4
2278278-04-7
KRAS inhibitor-15
2230873-75-1
Microtubule inhibitor 7
2416338-65-1
KRAS inhibitor-12
2230874-00-5
FabG1-IN-1
1051177-61-7
Sunobinop
1126793-40-5
HIV-1 inhibitor-24
2475658-75-2
Nur77 modulator 2
2055829-03-1
Tubulin inhibitor 25
2411697-71-5
MEIS-IN-1
2761326-82-1
Haloperidol lactate
53515-91-6
BET bromodomain inhibitor 2
2414195-69-8
Raltegravir sodium
1292804-07-9
HIV-1 inhibitor-34
2395777-45-2
Aurora A inhibitor 2
2412144-74-0
HIV-1 inhibitor-43
2493426-43-8
RUSKI-201 dihydrochloride
2320262-09-5
Topoisomerase I inhibitor 8
210346-40-0
NN-390
2490284-25-6
NR2F6 modulator-1
904449-84-9
UNC9994 hydrochloride
2108826-33-9
KRAS inhibitor-16
2230873-67-1
SW02
1010820-68-4
Myoferlin inhibitor 1
2366279-99-2
POLA1 inhibitor 1
2217671-41-3
BRD4 Inhibitor-23
2760307-53-5
HIV-1 inhibitor-46
332947-35-0
Microtubule inhibitor 6
2416338-64-0
Anticancer agent 32
2222930-76-7
Glucosylceramide synthase-IN-1
2601393-20-6
Lotrafiban
171049-14-2
Aurora Kinases-IN-2
2241914-86-1
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
Copyright 2007© ChemicalBook. All rights reserved.